Welcome to our dedicated page for Naturl Alt Intl SEC filings (Ticker: NAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Natural Alternatives International, Inc. (NAII) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a NASDAQ-listed issuer incorporated in Delaware, NAI submits annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with proxy materials such as the definitive proxy statement on Schedule 14A.
For a company in the nutritional supplements and medicinal and botanical manufacturing sector, Form 10-K and Form 10-Q are central sources of information on segment performance for private-label contract manufacturing and patent and trademark licensing, including CarnoSyn® beta-alanine royalty, licensing and raw material sales. These filings also describe factors affecting results, such as manufacturing costs, factory capacity utilization, and sales mix between segments.
Form 8-K current reports document material events. Recent examples include an amended credit facility with Wells Fargo Bank extending NAI’s revolving line of credit and adding collateral, a Waiver and Release Agreement in which Wells Fargo waived certain financial covenant defaults, and a Manufacturing Agreement with The Juice Plus+ Company covering Juice Plus+ products in 24 countries. Other 8-K filings summarize outcomes of the annual meeting of stockholders, including votes on director elections, amendments to equity incentive plans, and advisory votes on executive compensation.
NAI’s DEF 14A definitive proxy statement outlines governance matters, annual meeting logistics, and proposals submitted to shareholders, including board elections, equity plan amendments, auditor ratification, and advisory compensation votes. These materials help investors understand the company’s governance framework and shareholder voting results.
On Stock Titan, NAII filings are updated in near real time from EDGAR, and AI-powered summaries highlight the key points of lengthy documents such as 10-Ks, 10-Qs, and 8-Ks. Users can quickly see what changed in new filings, how credit agreements and manufacturing contracts are structured, and how shareholder approvals may affect equity plans and governance, without reading every page of the underlying documents.
NATURAL ALTERNATIVES INTERNATIONAL INC President, COO & Secretary Kenneth Wolf reported routine equity compensation activity. On March 6, 2026, 5,151 shares of common stock were transferred back to the company at $2.73 per share to cover his tax liability tied to the vesting of 9,166 restricted shares on March 7, 2026. He also received a grant of 15,000 shares of restricted stock under the company’s 2020 Omnibus Incentive Plan, which vest in three equal installments of 5,000 shares on March 7, 2027, March 7, 2028, and March 7, 2029. After these transactions, he directly holds 141,831 common shares.
NATURAL ALTERNATIVES INTERNATIONAL INC Chief Financial Officer Michael E. Fortin reported compensation-related stock activity. He received a grant of 12,000 shares of common stock as restricted stock under the company’s 2020 Omnibus Incentive Plan. In a related move, 4,308 shares were transferred back to the company at $2.73 per share to cover his tax liability upon vesting of 7,666 restricted shares on March 7, 2026. One-third of the new 12,000-share grant, or 4,000 shares, vests on each of March 7, 2027, March 7, 2028, and March 7, 2029. After these transactions, Fortin directly holds 58,554 common shares and indirectly holds 185 shares through an IRA.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux received a grant of 20,000 shares of common stock as restricted stock under the 2020 Omnibus Incentive Plan. Following this award, his direct holdings increased to 176,737 common shares.
On the same date, 3,484 shares were transferred back to the company at $2.73 per share to pay his tax liability arising from the vesting of 10,667 restricted shares on March 7, 2026, a tax-withholding disposition rather than an open-market sale. The new 20,000-share grant vests in three equal annual installments of 6,667, 6,667 and 6,666 shares on March 7, 2027, 2028 and 2029. He also reports additional indirect holdings through a family limited partnership, an IRA and custodial accounts.
Dunn Alan G reported acquisition or exercise transactions in this Form 4 filing.
Natural Alternatives International director Alan G. Dunn received a grant of 8,000 shares of Common Stock as restricted stock under the company’s 2020 Omnibus Incentive Plan. One-third vests on
Matherly Laura Kay reported acquisition or exercise transactions in this Form 4 filing.
NATURAL ALTERNATIVES INTERNATIONAL INC granted director Laura Kay Matherly 8,000 shares of restricted common stock as compensation under its 2020 Omnibus Incentive Plan. One-third of the award, or 2,667 shares, vests on
Ramanathan Guru reported acquisition or exercise transactions in this Form 4 filing.
Natural Alternatives International director Guru Ramanathan received a grant of 8,000 shares of restricted common stock as equity compensation under the company’s 2020 Omnibus Incentive Plan. These shares were granted at no cash cost and increase his direct holdings to 38,000 shares.
The restricted stock vests in three equal annual installments: 2,667 shares on March 7, 2027, 2,667 shares on March 7, 2028, and 2,666 shares on March 7, 2029. This structure is designed to vest over three years of continued board service.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux reported open-market purchases of the company’s common stock. Over three days, he bought a total of 1,250 shares at prices ranging from $2.75 to $2.80 per share, increasing his direct ownership.
After these purchases, his directly held stake rose to 160,221 common shares. The filing also lists additional indirect holdings in the company’s stock through a family limited partnership, an IRA, and custodial accounts for family members, reflecting both personal and family-related ownership positions.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux reported open-market purchases of a total of 1,000 shares of common stock, buying 500 shares at $2.85 on February 27, 2026 and 500 shares at $2.79 on March 2, 2026. Following these trades, his directly held stake rose to 158,971 shares. The filing also lists additional indirect holdings in a family limited partnership, an IRA, and several custodial accounts as of February 27, 2026.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO/Chairman and 10% owner Mark A. LeDoux reported buying additional common shares in the open market. On February 25–27, 2026, he made three open-market purchases totaling 1,250 shares at prices between $2.8000 and $2.8460 per share. After these transactions, his directly held stake rose to 157,971 common shares. He also reported indirect ownership positions held through the LeDoux Family Limited Partnership, an IRA, and several custodial accounts for family members, which are disclosed as separate indirect holdings.
Natural Alternatives International CEO and Chairman Mark A. LeDoux reported open-market purchases of company common stock. He bought 2,000 shares across three trades between February 20 and 24, 2026 at prices from $2.655 to $2.71 per share, increasing his direct holdings to 156,971 shares. He also reports indirect ownership positions through a family limited partnership, an IRA, and several custodial accounts, with updated share amounts for each as of February 20, 2026.